CureTech's Unattributed VC Round

CureTech raised a round of funding on September 17, 2013.

CureTech is a biotechnology company developing broad-spectrum, immune modulating products for the treatment and control of cancer. Building on the broad experience of its management, the company has e…

Articles about CureTech's Unattributed VC Round: